Bio-Rad Share Price
NYSE: BIO.B | HealthcareBio-Rad Stock Performance
Bio-Rad Share Price Chart
Bio-Rad Quarterly Profit & Loss
All figures in USD
Bio-Rad Annual Profit & Loss
All figures in USD
Bio-Rad Balance Sheet
All figures in USD Billion
Bio-Rad Cash Flow
All figures in USD Million
About Bio-Rad
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Bio-Rad Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Jul 2026 | $298.50 | $298.50 | +3.21% |
Jun 2026 | $289.23 | $289.23 | +15.65% |
Jul 2025 | $250.08 | $250.08 | +0.00% |
Jun 2025 | $250.08 | $250.08 | +0.00% |
May 2025 | $234.41 | $250.08 | +6.68% |
Apr 2025 | $241.99 | $234.41 | -3.13% |
Mar 2025 | $456.10 | $241.99 | -46.94% |
Feb 2025 | $456.10 | $456.10 | +0.00% |
Jan 2025 | $456.10 | $456.10 | +0.00% |
Dec 2024 | $456.10 | $456.10 | +0.00% |
Nov 2024 | $456.10 | $456.10 | +0.00% |
Oct 2024 | $456.10 | $456.10 | +0.00% |